Arrowhead Pharmaceuticals (NASDAQ:ARWR) will post its quarterly earnings results after the market closes on Tuesday, December 12th. Analysts expect Arrowhead Pharmaceuticals to post earnings of ($0.10) per share for the quarter.

Arrowhead Pharmaceuticals (ARWR) opened at $3.45 on Friday. Arrowhead Pharmaceuticals has a 1-year low of $1.20 and a 1-year high of $4.54. The company has a current ratio of 3.84, a quick ratio of 3.84 and a debt-to-equity ratio of 0.03.

A number of analysts recently weighed in on ARWR shares. ValuEngine raised shares of Arrowhead Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 24th. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $2.00 price objective (up from $1.00) on shares of Arrowhead Pharmaceuticals in a research note on Friday, September 15th. Chardan Capital reaffirmed a “neutral” rating on shares of Arrowhead Pharmaceuticals in a research note on Wednesday, September 13th. William Blair raised shares of Arrowhead Pharmaceuticals from a “market perform” rating to an “outperform” rating in a research note on Monday, September 18th. Finally, Piper Jaffray Companies raised shares of Arrowhead Pharmaceuticals from a “neutral” rating to an “overweight” rating and set a $5.50 price objective for the company in a research note on Monday, November 27th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $3.17.

WARNING: “Arrowhead Pharmaceuticals (ARWR) to Release Earnings on Tuesday” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://www.watchlistnews.com/arrowhead-pharmaceuticals-arwr-to-release-earnings-on-tuesday/1754761.html.

About Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals, Inc, formerly Arrowhead Research Corporation, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company’s therapies trigger the RNA interference mechanism to induce knockdown of target genes.

Earnings History for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

Receive News & Ratings for Arrowhead Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrowhead Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.